Viewing Study NCT00923520

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-01-29 @ 3:22 PM
Study NCT ID: NCT00923520
Status: COMPLETED
Last Update Posted: 2018-12-05
First Post: 2009-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
None Breast Cancer View
None Colon Cancer View
None Lung Cancer View
None Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumors View
None Phase I View
None Lymphoma View
None Dimethane Sulfonate (DMS612, NSC 281612) View
None Cancer View
None Solid Tumor View
None Renal Cell Cancer View
None Kidney Cancer View
None Breast Cancer View
None Colon Cancer View
None Lung Disease View
None Non-Hodgkin Lymphoma View
None NHL View